Figure 8.
(a) Viability of LNCaP and PC3 cells after exposure to doxorubicin-Plain-liposome, doxorubicin-P3-liposomes, free doxorubicin, and empty liposomes for 24 h. (b,c) Viability vs. exposure time plots for LNCaP and PC3 cells, respectively, exposed to doxorubicin-Plain-liposome, doxorubicin-P3-liposomes, and free doxorubicin ((doxorubicin) = 1 µM, * p < 0.05, ** p < 0.01).
